Cargando…

Associations of the baseline level and change in glycosylated hemoglobin A1c with incident hypertension in non-diabetic individuals: a 3-year cohort study

BACKGROUND: Diabetes mellitus increases the risk of developing hypertension. The relationship between glycosylated hemoglobin A1c (HbA1c) level and incident hypertension remains controversial. This study examined the associations of the baseline level and change in the HbA1c level over 3 years with...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Lijuan, Zhen, Donghu, Fu, Songbo, Sun, Weiming, Li, Hongli, Zhao, Nan, Hou, Lijie, Tang, Xulei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9014640/
https://www.ncbi.nlm.nih.gov/pubmed/35436969
http://dx.doi.org/10.1186/s13098-022-00827-8
_version_ 1784688225882734592
author Liu, Lijuan
Zhen, Donghu
Fu, Songbo
Sun, Weiming
Li, Hongli
Zhao, Nan
Hou, Lijie
Tang, Xulei
author_facet Liu, Lijuan
Zhen, Donghu
Fu, Songbo
Sun, Weiming
Li, Hongli
Zhao, Nan
Hou, Lijie
Tang, Xulei
author_sort Liu, Lijuan
collection PubMed
description BACKGROUND: Diabetes mellitus increases the risk of developing hypertension. The relationship between glycosylated hemoglobin A1c (HbA1c) level and incident hypertension remains controversial. This study examined the associations of the baseline level and change in the HbA1c level over 3 years with incident hypertension in non-diabetic individuals. METHODS: This community-based cohort study was conducted with 2591 individuals aged 40–75 years without hypertension or diabetes at baseline, who participated in a longitudinal (REACTION) study program. Questionnaires were administered during interviews, and anthropometric and laboratory measurements were performed at baseline (2011) and follow-up (2014–2015). Multivariate logistic regression models were applied to estimate odds ratios (ORs) and 95% confidence intervals (CIs) of incident hypertension. RESULTS: Over a median follow-up period of 3.08 years (interquartile range 3.00, 3.25), 384 (14.82%) subjects developed hypertension. In the fully adjusted linear regression models, change in HbA1c remained significantly associated with changes in systolic blood pressure and diastolic blood pressure [β-coefficient (95% CI), 4.421 (2.811–6.032), 1.681 (0.695–2.667)]. Logistic regression analyses showed that baseline HbA1c level was positively associated with incident hypertension in the unadjusted model; however, the association was no longer significant after further adjustment. Change in HbA1c was positively associated with the development of hypertension, both as a categorical variable stratified by tertiles [adjusted OR (95% CI) in the highest tertile was 1.690 (1.240–2.303) versus the lowest tertile)] and as a continuous variable [adjusted OR (95% CI), 1.242 (1.106–1.394)], independent of age, sex, body mass index, systolic blood pressure, fasting plasma glucose level, lipid profile, the HbA1c level at baseline and 3-year change in body mass index. CONCLUSIONS: A higher baseline HbA1c level was not an independent risk factor for incident hypertension, whereas the change in HbA1c was independently associated with a greater longitudinal increase in blood pressure and an increased risk of incident hypertension in non-diabetic individuals.
format Online
Article
Text
id pubmed-9014640
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-90146402022-04-19 Associations of the baseline level and change in glycosylated hemoglobin A1c with incident hypertension in non-diabetic individuals: a 3-year cohort study Liu, Lijuan Zhen, Donghu Fu, Songbo Sun, Weiming Li, Hongli Zhao, Nan Hou, Lijie Tang, Xulei Diabetol Metab Syndr Research BACKGROUND: Diabetes mellitus increases the risk of developing hypertension. The relationship between glycosylated hemoglobin A1c (HbA1c) level and incident hypertension remains controversial. This study examined the associations of the baseline level and change in the HbA1c level over 3 years with incident hypertension in non-diabetic individuals. METHODS: This community-based cohort study was conducted with 2591 individuals aged 40–75 years without hypertension or diabetes at baseline, who participated in a longitudinal (REACTION) study program. Questionnaires were administered during interviews, and anthropometric and laboratory measurements were performed at baseline (2011) and follow-up (2014–2015). Multivariate logistic regression models were applied to estimate odds ratios (ORs) and 95% confidence intervals (CIs) of incident hypertension. RESULTS: Over a median follow-up period of 3.08 years (interquartile range 3.00, 3.25), 384 (14.82%) subjects developed hypertension. In the fully adjusted linear regression models, change in HbA1c remained significantly associated with changes in systolic blood pressure and diastolic blood pressure [β-coefficient (95% CI), 4.421 (2.811–6.032), 1.681 (0.695–2.667)]. Logistic regression analyses showed that baseline HbA1c level was positively associated with incident hypertension in the unadjusted model; however, the association was no longer significant after further adjustment. Change in HbA1c was positively associated with the development of hypertension, both as a categorical variable stratified by tertiles [adjusted OR (95% CI) in the highest tertile was 1.690 (1.240–2.303) versus the lowest tertile)] and as a continuous variable [adjusted OR (95% CI), 1.242 (1.106–1.394)], independent of age, sex, body mass index, systolic blood pressure, fasting plasma glucose level, lipid profile, the HbA1c level at baseline and 3-year change in body mass index. CONCLUSIONS: A higher baseline HbA1c level was not an independent risk factor for incident hypertension, whereas the change in HbA1c was independently associated with a greater longitudinal increase in blood pressure and an increased risk of incident hypertension in non-diabetic individuals. BioMed Central 2022-04-18 /pmc/articles/PMC9014640/ /pubmed/35436969 http://dx.doi.org/10.1186/s13098-022-00827-8 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Liu, Lijuan
Zhen, Donghu
Fu, Songbo
Sun, Weiming
Li, Hongli
Zhao, Nan
Hou, Lijie
Tang, Xulei
Associations of the baseline level and change in glycosylated hemoglobin A1c with incident hypertension in non-diabetic individuals: a 3-year cohort study
title Associations of the baseline level and change in glycosylated hemoglobin A1c with incident hypertension in non-diabetic individuals: a 3-year cohort study
title_full Associations of the baseline level and change in glycosylated hemoglobin A1c with incident hypertension in non-diabetic individuals: a 3-year cohort study
title_fullStr Associations of the baseline level and change in glycosylated hemoglobin A1c with incident hypertension in non-diabetic individuals: a 3-year cohort study
title_full_unstemmed Associations of the baseline level and change in glycosylated hemoglobin A1c with incident hypertension in non-diabetic individuals: a 3-year cohort study
title_short Associations of the baseline level and change in glycosylated hemoglobin A1c with incident hypertension in non-diabetic individuals: a 3-year cohort study
title_sort associations of the baseline level and change in glycosylated hemoglobin a1c with incident hypertension in non-diabetic individuals: a 3-year cohort study
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9014640/
https://www.ncbi.nlm.nih.gov/pubmed/35436969
http://dx.doi.org/10.1186/s13098-022-00827-8
work_keys_str_mv AT liulijuan associationsofthebaselinelevelandchangeinglycosylatedhemoglobina1cwithincidenthypertensioninnondiabeticindividualsa3yearcohortstudy
AT zhendonghu associationsofthebaselinelevelandchangeinglycosylatedhemoglobina1cwithincidenthypertensioninnondiabeticindividualsa3yearcohortstudy
AT fusongbo associationsofthebaselinelevelandchangeinglycosylatedhemoglobina1cwithincidenthypertensioninnondiabeticindividualsa3yearcohortstudy
AT sunweiming associationsofthebaselinelevelandchangeinglycosylatedhemoglobina1cwithincidenthypertensioninnondiabeticindividualsa3yearcohortstudy
AT lihongli associationsofthebaselinelevelandchangeinglycosylatedhemoglobina1cwithincidenthypertensioninnondiabeticindividualsa3yearcohortstudy
AT zhaonan associationsofthebaselinelevelandchangeinglycosylatedhemoglobina1cwithincidenthypertensioninnondiabeticindividualsa3yearcohortstudy
AT houlijie associationsofthebaselinelevelandchangeinglycosylatedhemoglobina1cwithincidenthypertensioninnondiabeticindividualsa3yearcohortstudy
AT tangxulei associationsofthebaselinelevelandchangeinglycosylatedhemoglobina1cwithincidenthypertensioninnondiabeticindividualsa3yearcohortstudy